HMPL004-6599 Phase I Dose-escalating Study
Phase 1
Terminated
- Conditions
- Ulcerative ColitisCrohn Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2018-07-24
- Last Posted Date
- 2019-12-17
- Lead Sponsor
- Nutrition Science Partners Limited
- Target Recruit Count
- 32
- Registration Number
- NCT03597971
- Locations
- 🇦🇺
Linear Clinical Research, Perth, Western Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath